Multinationals Start 2021 Empty Handed In China National Reimbursement Race

But Broader IO Indications An Advantage?

 
• By Brian Yang
  
Jiangsu Hengrui Medicine
JIANGSU HENGRUI SCORES INSURANCE COVERAGE FOR PD-1 ANTIBODY • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip